AllianceBernstein’s Aurinia Pharmaceuticals AUPH Stock Holding History

AllianceBernstein’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.88M	Sell	126,556 -1,770	-1%	-$28.3K	﹤0.01%	2078
2026 Q1	$2.05M	Buy	128,326 +3,506	+3%	+$51.2K	﹤0.01%	1992
2025 Q4	$1.99M	Buy	124,820 +10,440	+9%	+$148K	﹤0.01%	2009
2025 Q3	$1.26M	Sell	114,380 -21,120	-16%	-$231K	﹤0.01%	2235
2025 Q2	$1.15M	Hold	135,500	–	–	﹤0.01%	2220
2025 Q1	$1.09M	Hold	135,500	–	–	﹤0.01%	2197
2024 Q4	$1.22M	Hold	135,500	–	–	﹤0.01%	2227
2024 Q3	$993K	Hold	135,500	–	–	﹤0.01%	2334
2024 Q2	$774K	Hold	135,500	–	–	﹤0.01%	2430
2024 Q1	$679K	Hold	135,500	–	–	﹤0.01%	2451
2023 Q4	$1.22M	Hold	135,500	–	–	﹤0.01%	2178
2023 Q3	$1.05M	Hold	135,500	–	–	﹤0.01%	2213
2023 Q2	$1.31M	Hold	135,500	–	–	﹤0.01%	2134
2023 Q1	$1.49M	Hold	135,500	–	–	﹤0.01%	2034
2022 Q4	$585K	Hold	135,500	–	–	﹤0.01%	2543
2022 Q3	$1.02M	Hold	135,500	–	–	﹤0.01%	2280
2022 Q2	$1.36M	Buy	135,500 +34,500	+34%	+$386K	﹤0.01%	2174
2022 Q1	$1.25M	Buy	+101,000	New	+$1.56M	﹤0.01%	2337
2021 Q2	–	Sell	-185,352	Closed	-$2.41M	–	3329
2021 Q1	$2.41M	Buy	185,352 +162,500	+711%	+$2.36M	﹤0.01%	1979
2020 Q4	$316K	Buy	+22,852	New	+$333K	﹤0.01%	2832

Other funds holding AUPH

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AllianceBernstein's AUPH Position: Q2 2026 in Review

AllianceBernstein reduced its Aurinia Pharmaceuticals (AUPH) stake by 1.4% in Q2 2026, selling an estimated $28.3K and leaving 126,556 shares worth $1.88M. The position accounts for ﹤0.01% of the portfolio, ranked #2078.

AllianceBernstein first reported a position in AUPH in Q4 2020 and has held it in 20 quarters since. The position peaked at $2.41M in Q1 2021. 283 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

AllianceBernstein held 126,556 shares of Aurinia Pharmaceuticals worth $1.88M as of Q2 2026.
AllianceBernstein sold 1,770 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $28.3K.
Aurinia Pharmaceuticals made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #2078 holding.
AllianceBernstein first reported a position in Aurinia Pharmaceuticals in Q4 2020 and has held it in 20 quarters since.
AllianceBernstein's Aurinia Pharmaceuticals position peaked at $2.41M in Q1 2021.
283 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.